O
ALXN

Ossiam’s Alexion Pharmaceuticals ALXN Stock Holding History

Ossiam’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,898
Closed -$922K – 479
2020
Q4 		$922K Sell
5,898
-16,457
-74% -$2.11M 0.03% 193
2020
Q3 		$2.56M Sell
22,355
-2,292
-9% -$247K 0.11% 122
2020
Q2 		$2.77M Buy
24,647
+21,350
+648% +$2.27M 0.18% 104
2020
Q1 		$296K Buy
3,297
+2,786
+545% +$273K 0.02% 300
2019
Q4 		$55K Sell
511
-60,876
-99% -$6.51M ﹤0.01% 458
2019
Q3 		$6.01M Buy
61,387
+61,144
+25,162% +$6.89M 0.42% 53
2019
Q2 		$32K Buy
+243
New +$31.3K ﹤0.01% 439
2019
Q1 		– Sell
-886
Closed -$86K – 336
2018
Q4 		$86K Buy
+886
New +$105K 0.01% 240

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return